Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and...
Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...
German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for...
French engineering and technology company Technip Energies has boosted its sustainable chemicals portfolio with the purchase of DSM’s biosuccinium technology. Financial...
Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply...
DSM has entered into an agreement to buy Prodap, a Brazilian animal nutrition and technology company. The deal remains subject to customary conditions and is expected to...
Repsol has announced plans to invest €105 million to build a plant for ultra-high molecular weight PE (UHMWPE) at its Puertollano complex in Spain. The company said the...
In an M&A market that is heating up, one mega deal begets another, as market watchers speculate on what the next big move might be, when it might come and which players...
